A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
Interleukin (IL)-17 as a Biomarker in Assessment of Bronchial Asthma Severity = إنترلوكين-17 كدليل حيوي غير نافذ في تقييم شدة الربو الشعبي
2017
Al-Azhar Medical Journal
Preserved Fulltext
Asthma is a serious global health problem affecting all age groups. Cytokines from T-helper 2 cells are believed to be critical contributors of asthma. Objective: Measuring the serum levels of IL-17 as non-invasive biomarkers to assess asthma severity. Patients and Method: A prospective case controlled study included forty patients were recruited from the outpatient clinic and inpatient of
doi:10.12816/0038267
fatcat:4k4vqdgqkrgathlrjpebrim53y